Patents by Inventor Swathi Pinnamaneni

Swathi Pinnamaneni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE
    Publication number: 20240000725
    Abstract: Disclosed herein is pharmaceutical compositions of Compound 1, and/or the hydroquinone form thereof, and methods useful for treating or suppressing a disease or disorder such as an ?-synucleinpathy, a tauopathy, an autistic spectrum disorder, a pervasive developmental disorder, a liver disease, and liver damage in a subject using such pharmaceutical compositions.
    Type: Application
    Filed: September 6, 2023
    Publication date: January 4, 2024
    Inventors: Swathi PINNAMANENI, Mandar V. DALI, Dhaval PATEL, Akm Nasir UDDIN
  • TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME
    Publication number: 20230405000
    Abstract: The present description relates to a tablet formulation of 2-[3-(2,2,6,6-tetramethylpiperidin-4-yl)-3H-[1,2,3]triazolo[4,5-c]pyridazin-6-yl]-5-(2H-1,2,3-triazol-2-yl)phenol, a compound for use in treating Huntington's disease, and a method of making the same.
    Type: Application
    Filed: November 12, 2021
    Publication date: December 21, 2023
    Inventors: Swathi Pinnamaneni, Akm Nasir Uddin, Mandar Vasant Dali
  • Pharmaceutical compositions comprising 2,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione
    Patent number: 11786486
    Abstract: Disclosed herein is pharmaceutical compositions of Compound 1, and/or the hydroquinone form thereof, and methods useful for treating or suppressing a disease or disorder such as an ?-synucleinpathy, a tauopathy, an autistic spectrum disorder, a pervasive developmental disorder, a liver disease, and liver damage in a subject using such pharmaceutical compositions.
    Type: Grant
    Filed: July 8, 2022
    Date of Patent: October 17, 2023
    Assignee: PTC THERAPEUTICS, INC.
    Inventors: Swathi Pinnamaneni, Mandar V. Dali, Dhaval Patel, Akm Nasir Uddin
  • PHARMACEUTICAL COMPOSITIONS COMPRISING 2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE
    Publication number: 20230022538
    Abstract: Disclosed herein is pharmaceutical compositions of Compound 1, and/or the hydroquinone form thereof, and methods useful for treating or suppressing a disease or disorder such as an ?-synucleinpathy, a tauopathy, an autistic spectrum disorder, a pervasive developmental disorder, a liver disease, and liver damage in a subject using such pharmaceutical compositions.
    Type: Application
    Filed: July 8, 2022
    Publication date: January 26, 2023
    Inventors: Swathi PINNAMANENI, Mandar V. DALI, Dhaval PATEL, Akm Nasir UDDIN
  • TABLET FOR USE IN TREATING HUNTINGTON'S DISEASE AND METHOD OF MAKING THE SAME
    Publication number: 20220151938
    Abstract: The present description relates to a tablet formulation of 7-(2,8-dimethylimidazo[1,2-b]pyridazin-6-yl)-5-fluoro-3-(piperidin-4-yl)benzo[e][1,2,4]triazine, a compound for use in treating Huntington's disease, and a method of making the same.
    Type: Application
    Filed: January 28, 2022
    Publication date: May 19, 2022
    Applicant: PTC Therapeutics, Inc.
    Inventor: Swathi Pinnamaneni